Covered recipient · General Payments record
JEFFREY S LAMBERT
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$853.68
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $285.37 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $72.17 | 3 |
| PFIZER INC. | $47.06 | 3 |
| Xeris Pharmaceuticals, Inc. | $44.55 | 2 |
| Lilly USA, LLC | $38.88 | 2 |
| Merck Sharp & Dohme Corporation | $34.09 | 2 |
| ABBVIE INC. | $17.51 | 1 |
| GlaxoSmithKline, LLC. | $17.34 | 1 |
| DAVOL INC. | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.51 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104132414 | CMS |
| Amgen Inc. | $26.50 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117304679 | CMS |
| Amgen Inc. | $30.78 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117304681 | CMS |
| Amgen Inc. | $14.89 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111627736 | CMS |
| Davol Inc. | $13.77 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127659601 | CMS |
| GlaxoSmithKline, LLC. | $17.34 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116437485 | CMS |
| Lilly USA, LLC | $20.58 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135040081 | CMS |
| Lilly USA, LLC | $18.30 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135061177 | CMS |
| Merck Sharp & Dohme LLC | $13.99 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141969705 | CMS |
| Merck Sharp & Dohme LLC | $20.10 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141943353 | CMS |
| PFIZER INC. | $15.72 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131245312 | CMS |
| PFIZER INC. | $14.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131242222 | CMS |
| PFIZER INC. | $16.43 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131938469 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.58 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144598354 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.97 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144598356 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.